News, September 23, 2009 FDA Safety Changes: Actonel, Gardasil, Myfortic The FDA has approved safety labeling revisions for risedronate sodium tablets, human papillomavirus quadrivalent ...

Risedronate is the latest of the bisphosphonates to be used for the management of resorptive bone disease. Clinical improvements, assessed by the incidence of fracture and changes in bone mineral ...